% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 43

Loading Chart...

5 inventors (with patents filed for the assignee):

Raymond A Miller (2 out of 6 patents)

Bruce Branchaud (1 out of 20 patents)

Bruce A Freeman (1 out of 32 patents)

4. Diane Jorkasky (1 out of 1 patent)

5. Daniel Joseph Cushing (1 out of 12 patents)

5 patents: Sort by Forward Citations

1. 10537541 - Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid (2020-01-21),

2. 9790167 - Vinyl substituted fatty acids (2017-10-17),

3. 9663444 - Heteroatom containing substituted fatty acids (2017-05-30),

4. 9271952 - Compositions and methods for treating nephropathy (2016-03-01),

5. 8686167 - Heteroatom containing substituted fatty acids (2014-04-01),

Company Overview

Complexa Inc. is a biopharmaceutical company focused on the development of novel treatments for serious metabolic diseases. Our innovative approach to drug discovery and development is driven by cutting-edge research and a dedicated team of scientists. Our lead product candidate has shown promising results in clinical trials, highlighting our commitment to improving patient outcomes and addressing unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#17 in Berwyn, PA

#1,868 in Pennsylvania

#51,570 in US

Berwyn, PA, United States of America

Complexa Inc.

Forward Citations = 43

5 inventors:

Raymond A Miller (2 out of 6 patents)

Bruce Branchaud (1 out of 20 patents)

Bruce A Freeman (1 out of 32 patents)

4. Diane Jorkasky (1 out of 1 patent)

5. Daniel Joseph Cushing (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Complexa Inc.. Retrieved from https://idiyas.com/company/complexa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]